As the first barrier to prevent the spread of the epidemic, "pathogenic microorganism detection" has become a crucial step in epidemic prevention and control across the globe. “ Nucleic acid detection, antibody detection, clinical detection and other professional terms of virus detection have also come into the public view. With the enhancement of people's awareness of epidemic prevention, the support of policies and the deepening of international cooperation, scientists are doing their best to carry out the innovation iteration of detection methods, and the global virus detection is in a period of rapid development.
Novel coronavirus pneumonia will be held in the future. The joint venture will be held by the future forum and the ZhenFund. Through the way of cross ocean connection, we will set up a series of senior practitioners, frontiers, developers, researchers and start-ups in the field of Virology, pathology, inspection and quarantine, focusing on the technical differences of new crown pneumonia detection, and the development trend of detection industry.

Moderator

Xing YANG, Founder and Chairman of Accunome

Keynote Speech

"Application of NGS and CRISPR in the detection of new crown"-Jun WANG, Founder and CEO of MATRIDX
"Advantages of digital PCR technology in new crown detection"- Yaqi WANG, Founder and Chairman of RainSure Scientific
"Strategies and techniques for applying for FDA emergency use authorization"-Yongqiang WANG, Clinical laboratory manager of MacroGenics

Participants

- Le CONG, Member of Future Forum YOSIA, Assistant Professor of Pathology and Assistant Professor of Genetics, Investigator, Stanford Cancer Institute, Wu Tsai Neuroscience Institute, Bio-X Institute Stanford University School of Medicine
-Jingbo XU, Senior in Vitro Diagnostic Practitioner
-Dazhi JIN, Researcher of Hangzhou Medical College, Discipline Leader of Laboratory Medicine College of Zhejiang Provincial People's hospital